Calcium Release Deficiency Syndrome clinical trials at UCSF

1 research study open to eligible people

Calcium release deficiency syndrome is a genetic disorder that disrupts heart rhythms. UCSF is researching this condition through clinical trials. These studies focus on how changes in the RYR2 gene affect heart rhythm and health.

Showing trials for

  • International CRDS Registry

    open to all eligible people

    Calcium Release Deficiency Syndrome (CRDS) is a newly discovered genetic arrhythmia syndrome that confers a risk of life-threatening arrhythmias secondary to RYR2 loss-of-function. The International CRDS registry has been designed to facilitate large-scale evaluation of CRDS, including its phenotypic spectrum, approaches to risk stratification, and optimal treatment strategies.

    San Francisco, California and other locations

Our lead scientists for Calcium Release Deficiency Syndrome research studies include .

Last updated: